Journals / Güncel Retina Dergisi / 2017 / Cilt: 1 - Sayı: 2

Nutritional Therapy in Dry-form (Non-Neovascular) Age Related Macular Degeneration

Kuru Tip (Non-Neovasküler) Yaşa Bağlı Maküla Dejenerasyonunda Nutrisyonel Tedavi

Pages
135–144
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This review mentions about the nutritional therapy in dry-type AMD

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Age-related macular degeneration (AMD) is a progressive degenerative disorder of the macula in which central vision becomes impaired and leading cause of blindness in adults older than 55 years.
📊
Key Findings & Data:Multiple factors have been proposed for the pathogenesis of AMD including genetic susceptibility interacting with environmental and systemic health factors.
💡
Conclusion & Impact:This review mentions about the nutritional therapy in dry-type AMD
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Age-related macular degeneration (AMD) is a progressive degenerative disorder of the macula in which central vision becomes impaired and leading cause of blindness in adults older than 55 years. Multiple factors have been proposed for the pathogenesis of AMD including genetic susceptibility interacting with environmental and systemic health factors. Nowadays, treatment options for dry-form AMD are limited. Among these treatments, nutritional therapy is at the forefront. This review mentions about the nutritional therapy in dry-type AMD

Özet

Yaşa bağlı maküla dejenerasyonu (YBMD), santral görmeden sorumlu makülanın dejeneratif bir hastalığıdır ve 55 yaş üstünde körlüğün önde gelen sebebidir. YBMD patogenezinde çevresel ve sistemik faktörlerle etkinleşen, genetik yatkınlığı da içeren birçok faktörün önemli olduğu bilinmektedir. Günümüzde kuru tip YBMD de tedavi seçenekleri sınırlıdır. Bu tedaviler içeresinde nutrisyonel tedavi ön plana çıkmaktadır. Bu derlemede, kuru Tip YBMD de nutrisyonel tedavi ele alınmıştır

🔖

Cite This Article

ÇITIRIK, M., İLHAN, Ç., TEKE, M. Y. (2017). Nutritional Therapy in Dry-form (Non-Neovascular) Age Related Macular Degeneration. Güncel Retina Dergisi, Cilt: 1 - Sayı: 2, 135–144. https://ajindex.com/articles/196203

References (15)

  1. Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014; 2(2): e106-16
  2. Cousins SW. Role of Mitochondrial Dysfunction in Dry Age-Related Macular Degeneration. Retina Today. 2015; May/June: 83-86
  3. Roman K, Bressler N. Profile of a Potential Treatment for Geographic Atrophy. Retina Today. 2015; July/August: 92-96
  4. Augood CA, Vingerling JR, de Jong PT, Chakravarthy U, Seland J, Soubrane G, et al. Prevalence of age-related maculopathy in older Europeans: the European Eye Study (EUREYE). Arch Ophthalmol. 2006; 124(4): 529-35
  5. Karabulut H, Gülay MŞ. Serbest radikaller. MAKÜ Sag. Bil. Enst. Derg. 2016; 4(1): 50-59
  6. Koçyiğit A, Selek Ş. Eksojen antioksidanlar iki yönü keskin kılıçlardır. Bezmialem Science 2016; 4 (2): 70-5
  7. Çaylak E. Hayvan ve bitkilerde oksidatif stres ile antioksidanlar. Tıp Araş- tırmaları Dergisi: 2011; 9 (1): 73-83 8- Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no
  8. Arch Ophthalmol. 2001; 119(10): 1417-36
  9. Yazar Z, Zırığ HI. Kuru Tip Yaşa Bağlı Maküla Dejeneresansı Tedavisi. Ret-Vit 2010;18 (4): 253-262
  10. Bone RA, Landrum JT, Friedes LM, Gomez CM, Kilburn MD, Menendez E, Vidal I,Wang W. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res. 1997; 64(2): 211-8
  11. Koçak N, Kaya M, Kaynak S. Maküla pigment optik dansitesinin yaşa bağlı değişim analizi. Turk J Ophthalmol 2010; 40 (5): 260-265
  12. İnan UU. Patogenez, Genetik, Sabit ve Değişebilir Risk Faktörleri. Turkiye Klinikleri J Ophthalmol-Special Topics 2015; 8(1): 11-9
  13. Yıldız P, Dönderici Ö. Beyin Sağlığında Beslenmenin Etkisi. Osmangazi Tıp Dergisi, 2016; 38 (Özel Sayı 1): 8-12
  14. Okçu Z, Keleş F. Kalp-Damar Hastalıkları ve Antioksidanlar. Atatürk Üniv. Ziraat Fak. Derg. 2009; 40 (1): 153-160. 15- van Leeuwen R, Boekhoorn S, Vingerling JR, Witteman JC, Klaver CC, Hofman A, et al. Dietary intake of antioxidants and risk of age-related macular degeneration. JAMA. 2005; 294 (24): 3101-7
  15. Yin J, Thomas F, Lang JC, Chaum E. Modulation of oxidative stress responses in the human retinal pigment epithelium following treatment with vitamin C. J Cell Physiol. 2011; 2